4//SEC Filing
BRENNER LOUIS MD 4
Accession 0000899243-20-034478
CIK 0001624658other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:15 PM ET
Size
9.4 KB
Accession
0000899243-20-034478
Insider Transaction Report
Form 4
BRENNER LOUIS MD
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2020-12-17+247,932→ 247,932 total - Exercise/Conversion
Restricted Stock Units
2020-12-17−247,932→ 0 total→ Common Stock (247,932 underlying) - Sale
Common Stock
2020-12-17$1.36/sh−103,116$140,238→ 144,816 total
Footnotes (3)
- [F1]The sale reported on this Form 4 was effected by the Reporting Person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]On December 2, 2019, the Reporting Person was granted 123,966 restricted stock units, vesting in two equal installments on June 2, 2020 and December 2, 2020 (the "December 2019 Grant"). On May 28, 2020, the reporting person was granted an additional 123,966 restricted stock units (the "May 2020 Grant") and the December 2019 Grant was amended to vest in full, together with the May 2020 Grant, on December 2, 2020. 247,932 shares of common stock were distributed to the Reporting Person on December 17, 2020 following the vesting of the restricted stock units from the December 2019 Grant and the May 2020 Grant
Documents
Issuer
Allena Pharmaceuticals, Inc.
CIK 0001624658
Entity typeother
Related Parties
1- filerCIK 0001389500
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:15 PM ET
- Size
- 9.4 KB